Annual report pursuant to Section 13 and 15(d)

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.24.1
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Product revenue, net $ 59,662 $ 70,995
Collaboration revenue 5,229 1,882
Other revenue 19,519 2,674
Net revenue 84,513 75,743
Related Party    
Revenue - related party 103 192
Qbrexza    
Product revenue, net 25,410 26,715
Accutane    
Product revenue, net 20,168 18,373
Amzeeq    
Product revenue, net 6,201 7,242
Zilxi    
Product revenue, net 1,962 2,273
Targadox    
Product revenue, net 3,204 7,972
Exelderm    
Product revenue, net 2,395 3,463
Ximino    
Product revenue, net 287 4,957
Luxamend    
Product revenue, net 35 0
Royalties    
Other revenue   200
Rapifort    
Other revenue $ 19,000 $ 2,500